Displaying drugs 9051 - 9075 of 9162 in total
Dociparstat sodium
Investigational
Abafungin
Investigational
Onercept
Investigational
Cariporide
Investigational
TBC-3711
TBC3711 is a next-generation endothelin antagonist that is being studied through oral and intravenous formulations by Encysive Pharmaceuticals.
Investigational
SNS-032
Investigational
Zenarestat
Experimental
alpha-Conotoxin VC 1.1
Investigational
Matched Iupac: … carbamoyl-30-(carbamoylmethyl)-24,45-bis(carboxymethyl)-48-(hydroxymethyl)-27-[(4-hydroxyphenyl)methyl]-21 …
G4460
Investigational
Vasomera
Investigational
RG-7795
Investigational
PRX-07034
Investigational
Annamycin
Investigational
FT516
FT516 is an investigational and engineered off-the-shelf natural killer (NK) cell therapy originating from induced pluripotent stem cells (iPSC). This compound expresses a high-affinity 158V, CD16 (hnCD16) Fc receptor that has an enhanced binding ability to tumor-targeting antibodies, and is resistant to downregulation. FT516 is currently being tested against acute...
Investigational
Alicaforsen
Investigational
Refametinib
Investigational
AT-527
Investigational
RAV12
RAV12 is investigated for use/treatment in solid tumors. RAV12 is a solid. RAV12 is a chimeric antibody that recognizes RAAG12, an N-linked carbohydrate antigen found on gastric, colon, pancreatic, prostate, ovarian, breast, and kidney cancer cells.
Investigational
Latiglutenase
Investigational
Elvucitabine
Investigational
Bardoxolone methyl
Investigational
Siplizumab
Investigational
Displaying drugs 9051 - 9075 of 9162 in total